Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Henriette Breunis"'
Autor:
Efthymios Papadopoulos, Andy Kin On Wong, Sharon Hiu Ching Law, Lindsey Ze Jing Zhang, Henriette Breunis, Urban Emmenegger, Shabbir M H Alibhai
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0286381 (2023)
IntroductionSarcopenia is common in men with metastatic castrate-resistant prostate cancer (mCRPC) and has been largely assessed opportunistically through computed-tomography (CT) scans, excluding measures of muscle function. Therefore, the impact of
Externí odkaz:
https://doaj.org/article/9f549bb6ac264c3593988be150701da9
Autor:
Martine Puts, Naser Alqurini, Fay Strohschein, Rama Koneru, Ewa Szumacher, Caroline Mariano, Johanne Monette, Tina Hsu, Sarah Brennenstuhl, Bianca McLean, Aria Wills, Arielle Berger, Eitan Amir, Lindy Romanovsky, Anson Li, Rajin Mehta, Monika Krzyzanowska, Christine Elser, Raymond Jang, Anca Prica, Doreen Wan-Chow-Wah, Eric Pitters, Urban Emmenegger, Ines B. Menjak, Simon Bergman, Manon Lemonde, Henriette Breunis, Francois Béland, Shabbir M.H. Alibhai
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
PURPOSE American Society of Clinical Oncology recommends that older adults with cancer being considered for chemotherapy receive geriatric assessment (GA) and management (GAM), but few randomized controlled trials have examined its impact on quality
Autor:
Sebastien J. Hotte, Shabbir M.H. Alibhai, Aaron R. Hansen, George Tomlinson, Richard Gregg, Urban Emmenegger, Neil Fleshner, Narhari Timilshina, Henriette Breunis, Anthony M. Joshua, Padraig Warde
Publikováno v:
Cancer. 127:2587-2594
BACKGROUND Because multiple treatments are available for metastatic castrate-resistant prostate cancer (mCRPC) and most patients are elderly, the prediction of toxicity risk is important. The Cancer and Aging Research Group (CARG) tool predicts chemo
Autor:
Gregory Feng, Milothy Parthipan, Henriette Breunis, Martine Puts, Urban Emmenegger, Narhari Timilshina, Aaron R. Hansen, Antonio Finelli, Monika K. Krzyzanowska, Andrew Matthew, Hance Clarke, Daniel Santa Mina, Enrique Soto-Perez-de-Celis, George Tomlinson, Shabbir M.H. Alibhai
Publikováno v:
Journal of Geriatric Oncology. 14:101469
Autor:
Valerie S. Kim, Helen Yang, Narhari Timilshina, Henriette Breunis, Urban Emmenegger, Richard Gregg, Aaron R. Hansen, George Tomlinson, Shabbir M.H. Alibhai
Publikováno v:
Journal of Geriatric Oncology. 14:101417
Autor:
Helen Yang, Valerie S. Kim, Narhari Timilshina, Henriette Breunis, Urban Emmenegger, Richard Gregg, Aaron Hansen, George Tomlinson, Shabbir M.H. Alibhai
Publikováno v:
Journal of Geriatric Oncology. 14:101395
Autor:
Milothy Parthipan, Gregory Feng, Nelly Toledano, Valentina Donison, Henriette Breunis, Abirami Sudharshan, Urban Emmenegger, Antonio Finelli, Padraig Warde, Enrique Soto-Perez-de-Celis, Monika Krzyzanowska, Andrew Matthew, Hance Clarke, Daniel Santa Mina, Shabbir M.H. Alibhai, Martine Puts
Publikováno v:
Journal of Geriatric Oncology. 14:101397
Autor:
Narhari Timilshina, Aaron R. Hansen, Richard Gregg, George Tomlinson, Gregory Feng, Urban Emmenegger, Shabbir M.H. Alibhai, Neil Fleshner, Henriette Breunis, Anthony M. Joshua, Padraig Warde
Publikováno v:
JAMA Network Open
Key Points Question Are commonly used treatments for metastatic castration-resistant prostate cancer (mCRPC) associated with a decline in cognitive function in older men? Findings This cohort study followed up 198 men aged 65 years or older with mCRP
Autor:
Allison Loucks, Shabbir M.H. Alibhai, Arielle Berger, Rana Jin, Daniel Yokom, Ali Taqi Syed, Martine Puts, Narhari Timilshina, Henriette Breunis, Sarah Watt, Leigha Rowbottom
Publikováno v:
Journal of Geriatric Oncology. 10:229-234
Geriatric assessment (GA) is recommended for older adults ≥ 70 years with cancer to guide treatment selection. Screening tools such as the Vulnerable Elders Survey (VES-13) and G6 have been used to identify patients at highest need of GA. Whether e
Autor:
Shabbir M.H. Alibhai, Henriette Breunis, Narhari Timilshina, Gregory Feng, Milothy Parthipan, Abirami Sudharshan, Aaron Richard Hansen, Antonio Finelli, Padraig Warde, George Tomlinson, Monika K. Krzyzanowska, Andrew Matthew, Hance Clarke, Daniel Santa Mina, Enrique Soto Pérez de Celis, Martine Puts, Urban Emmenegger
Publikováno v:
Journal of Clinical Oncology. 40:12056-12056
12056 Background: Emerging data support multiple benefits of RSM during chemotherapy to improve outcomes. These studies do not focus on older adults and do not include non-chemotherapy strategies. mPC represents a major burden in older men. Although